Oncology Clinical Trials in Fort Worth, TX

As of August 2026, 81 paid clinical trials are recruiting for Oncology in Fort Worth, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

81 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Fort Worth, TX.

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for Non-Small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Fort Worth, Kingwood +47 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06357533·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Conditions in Oncology (Fort Worth, TX)

Non-small cell lung cancer (NSCLC)· 16 Solid tumor· 13 Breast cancer· 7 Ovarian cancer· 7 Endometrial cancer· 7 Gastric cancer· 6 Hematologic malignancy· 5 Neuroblastoma· 5 Cancer (any)· 5 Fallopian tube cancer· 4 Acute myeloid leukemia (AML)· 4 Colorectal cancer· 3 Pancreatic cancer· 3 Prostate cancer· 3 Cervical cancer· 3 Leukemia (other)· 3 Mesothelioma· 3 Metastatic breast cancer· 2 Triple-negative breast cancer· 2 Gastroesophageal junction cancer· 2 Biliary tract cancer· 2 Kidney cancer· 2 Chronic lymphocytic leukemia (CLL)· 2 Myelodysplastic syndromes (MDS)· 2 Hodgkin lymphoma· 2 Non-Hodgkin lymphoma· 2 Head and neck cancer· 2 Lung cancer· 1 Liver cancer· 1 Bladder cancer· 1 Uterine cancer· 1 Multiple myeloma· 1 Acute lymphoblastic leukemia· 1 Myeloproliferative neoplasm· 1 Diffuse large B-cell lymphoma (DLBCL)· 1 Follicular lymphoma· 1 Small lymphocytic lymphoma· 1 Melanoma· 1 Skin cancer· 1 Osteosarcoma· 1 Rhabdomyosarcoma· 1